Boehringer Ingelheim International GmbH

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Founded in 1885, Boehringer develops, makes, and markets medications for humans and animals. The company concentrates on developing innovative therapies that can extend patients' lives. In animal health, Boehringer Ingelheim is one of the world's leading providers of vaccines, therapeutics and preventative care offering that protect animals from disease and pain. Prescription drugs include treatments for respiratory ailments, heart diseases, metabolic diseases, skin and retinal diseases, and mental disorders. Boehringer also offers vaccines, parasiticides and therapeutics for farm animals and pets. The founding Boehringer family controls the firm through parent C.H. Boehringer Sohn.

Wholesale Trade; Drugs and Druggists' Sundries Merchant Wholesalers; Office Administrative Services; Merchant Wholesalers, Nondurable Goods

Wholesale Trade-Durable Goods; Wholesale Trade-Nondurable Goods; Drugs, Proprietaries, and Sundries; Management Services; Wholesale Trade-Nondurable Goods

$10566.41M